Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib mesylate when the patent is expiring in india?Dabrafenib patent expiration?How does insurance coverage impact nivolumab's duration?When oxcarbazepine patent expired?How many years does kadcyla's market exclusivity last?
See the DrugPatentWatch profile for pembrolizumab
Pembrolizumab is an antibody that targets the programmed death-1 (PD-1) receptor on immune cells. The ligand for PD-1 is PD-L1 (also called B7-H1). Sources: 1. DrugPatentWatch.com – Pembrolizumab (Keytruda) drug information
Other Questions About Pembrolizumab :